Cargando…

Electronic Patient Reported Outcome (ePRO) Measures in Patients with Soft Tissue Sarcoma (STS) Receiving Palliative Treatment

SIMPLE SUMMARY: Therapeutic options for advanced soft tissue sarcoma (STS) are limited. Health-related quality of life (HRQoL), along with traditional outcome parameters such as tumor control and toxicity, is one of the most important endpoints for palliative STS treatment. The PazoQoL prospective,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hofer, Silvia, Hentschel, Leopold, Richter, Stephan, Blum, Veronika, Kramer, Michael, Kasper, Bernd, Riese, Christoph, Schuler, Markus K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954494/ https://www.ncbi.nlm.nih.gov/pubmed/36831574 http://dx.doi.org/10.3390/cancers15041233

Ejemplares similares

Mobile eHealth solution (ePRO)
por: Saganowski, Stanisław, et al.
Publicado: (2015)

Quality of life and added value of a tailored palliative care intervention in patients with soft tissue sarcoma undergoing treatment with trabectedin: a multicentre, cluster-randomised trial within the German Interdisciplinary Sarcoma Group (GISG)
por: Hentschel, Leopold, et al.
Publicado: (2020)

Phenoxy herbicides, chlorophenols, soft-tissue sarcoma (STS) and malignant lymphoma.
por: Hardell, L.
Publicado: (1993)

Evaluation of the accuracy of algorithms to identify soft tissue sarcoma (STS) in administrative claims
por: Princic, Nicole, et al.
Publicado: (2020)

A cluster-randomised, controlled proof-of-concept study to explore the feasibility and effect of a patient-directed intervention on quality of life in patients with advanced soft tissue sarcoma
por: Schuler, Markus, et al.
Publicado: (2017)

A phase II study of ENMD-2076 in advanced soft tissue sarcoma (STS)
por: Veitch, Zachary, et al.
Publicado: (2019)

Electronic patient-reported outcome (ePRO) application for patients with prostate cancer
por: Mohseni, Majid, et al.
Publicado: (2023)

A Phase II Study of Docetaxel and Epirubicin in Advanced Adult Soft Tissue Sarcomas (STS)
por: Kalofonos, Haralabos P., et al.
Publicado: (2004)

Prognostic Significance of Bone Metastasis in Soft Tissue Sarcoma Patients Receiving Palliative Systemic Therapy: An Explorative, Retrospective Pooled Analysis of the EORTC-Soft Tissue and Bone Sarcoma Group (STBSG) Database
por: Kantidakis, Georgios, et al.
Publicado: (2022)

AquaScouts: ePROs Implemented as a Serious Game for Children With Cancer to Support Palliative Care
por: Hoffmann, Stefan, et al.
Publicado: (2021)

Treatment patterns and survival in an exhaustive French cohort of pazopanib-eligible patients with metastatic soft tissue sarcoma (STS)
por: Ray-Coquard, Isabelle, et al.
Publicado: (2017)

Key methodological considerations for usability testing of electronic patient-reported outcome (ePRO) systems
por: Aiyegbusi, Olalekan Lee
Publicado: (2019)

Capturing Patient-Reported Outcome (PRO) Data Electronically: The Past, Present, and Promise of ePRO Measurement in Clinical Trials
por: Coons, Stephen Joel, et al.
Publicado: (2014)

Potential benefit of hormonal therapy for non-uterine soft tissue sarcoma (STS) – a case report and literature review
por: Li, Li, et al.
Publicado: (2013)

ePro-ClearSee: a simple immunohistochemical method that does not require sectioning of plant samples
por: Nagaki, Kiyotaka, et al.
Publicado: (2017)

Content validity and ePRO usability of the BPI-sf and “worst pain” item with pleural and peritoneal mesothelioma
por: Gelhorn, Heather L., et al.
Publicado: (2018)

Erratum to: Capturing Patient-Reported Outcome (PRO) Data Electronically: The Past, Present, and Promise of ePRO Measurement in Clinical Trials
por: Coons, Stephen Joel, et al.
Publicado: (2015)

Financial toxicity in sarcoma patients and survivors in Germany: results from the multicenter PROSa study
por: Büttner, Matthias, et al.
Publicado: (2021)

Efficacy and safety of Dexrazoxane (DRZ) in sarcoma patients receiving high cumulative doses of anthracycline therapy – a retrospective study including 32 patients
por: Schuler, Markus K., et al.
Publicado: (2016)

CINSARC in high‐risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG‐STS 1001 study
por: Frezza, Anna Maria, et al.
Publicado: (2022)

MyPal ADULT study protocol: a randomised clinical trial of the MyPal ePRO-based early palliative care system in adult patients with haematological malignancies
por: Scarfò, Lydia, et al.
Publicado: (2021)

The challenge of finding new therapeutic avenues in soft tissue sarcomas
por: Kasper, Bernd
Publicado: (2019)

eProS—a database and toolbox for investigating protein sequence–structure–function relationships through energy profiles
por: Heinke, Florian, et al.
Publicado: (2013)

Implementation of a cloud-based electronic patient-reported outcome (ePRO) platform in patients with advanced cancer
por: Generalova, Olga, et al.
Publicado: (2021)

MyPal-Child study protocol: an observational prospective clinical feasibility study of the MyPal ePRO-based early palliative care digital system in paediatric oncology patients
por: Meyerheim, Marcel, et al.
Publicado: (2021)

TIM-3 Qualifies as a Potential Immunotherapeutic Target in Specific Subsets of Patients with High-Risk Soft Tissue Sarcomas (HR-STS)
por: Berclaz, Luc M., et al.
Publicado: (2023)

Feasibility study on collecting patient‐reported outcomes from breast cancer patients using the LINE‐ePRO system
por: Hayashida, Tetsu, et al.
Publicado: (2022)

Working situation and burden of work limitations in sarcoma patients: results from the multi-center prospective PROSa study
por: Zapata Bonilla, Sergio Armando, et al.
Publicado: (2023)

ePRO symptom follow-up of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy is feasible and enhances the quality of patient care: a prospective multicenter study
por: Iivanainen, Sanna, et al.
Publicado: (2023)

Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata
por: Woll, Penella J., et al.
Publicado: (2023)

Psychometric validation and testing of the 10-item pediatric daily chest-related electronic patient reported outcome (ePRO) diary
por: Arbuckle, Rob, et al.
Publicado: (2023)

Electronic patient-reported outcomes in clinical kidney practice (ePRO Kidney): a process evaluation of educational support for clinicians
por: Schick-Makaroff, Kara, et al.
Publicado: (2023)

CUL4A, ERCC5, and ERCC1 as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) Study
por: Moura, David S., et al.
Publicado: (2020)

Inhibition of AKT-Signaling Sensitizes Soft Tissue Sarcomas (STS) and Gastrointestinal Stromal Tumors (GIST) to Doxorubicin via Targeting of Homology-Mediated DNA Repair
por: Boichuk, Sergei, et al.
Publicado: (2020)

The Phosphatases STS1 and STS2 Regulate Hematopoietic Stem and Progenitor Cell Fitness
por: Zhang, Jing, et al.
Publicado: (2015)

The provider perspective: investigating the effect of the Electronic Patient-Reported Outcome (ePRO) mobile application and portal on primary care provider workflow
por: Hans, Parminder K., et al.
Publicado: (2017)

Research Activities in the STS Division
Publicado: (1957)

Research and Development Activities in STS
Publicado: (1957)

Research and Development Activities in STS
Publicado: (1958)

STS-1 and STS-2, Multi-Enzyme Proteins Equipped to Mediate Protein–Protein Interactions
por: Hayes, Barbara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q647mc8fffvl206bmfrbjv8hd0